BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $328,794 | -39.3% | 7,505 | -8.8% | 0.00% | -50.0% |
| Q3 2022 | $542,000 | +30.6% | 8,227 | +0.2% | 0.01% | +33.3% |
| Q2 2022 | $415,000 | -21.0% | 8,210 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $525,000 | -40.3% | 8,210 | -0.1% | 0.01% | -50.0% |
| Q4 2021 | $880,000 | +4.3% | 8,219 | +0.1% | 0.01% | +27.3% |
| Q3 2021 | $844,000 | +3.2% | 8,212 | -11.7% | 0.01% | +10.0% |
| Q2 2021 | $818,000 | -2.0% | 9,300 | +8.3% | 0.01% | -16.7% |
| Q1 2021 | $835,000 | -0.7% | 8,589 | +14.5% | 0.01% | 0.0% |
| Q4 2020 | $841,000 | +21.0% | 7,500 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $695,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |